Session Details

Plasminogen Activator Inhibitors and SERPINS 1

Tuesday, 23 March 2004 14:00 -15:15

Co-Chair David J Loskutoff The Scripps Research InstituteUnited States
Co-Chair Eric Rondeau Hopital TenonFrance

Identification and Pharmacological Modulation of a Caveolae Dependent Signalling that Upregulates PAI-1 During Insulin Resistance
  • Mr Joshi Venugopal, Friedrich Miescher Institute, Switzerland
  • Paclitaxel and Rapamycin Induce Expression of Murine Plasminogen Activator Inhibitor-1 and Activate the Human 3KB-PAI-1 Promoter in Transgenic Mice
  • Dr James AS Muldowney, Vanderbilt University Medical Center, United States
  • Plasminogen Activators Regulate the Activation of TGF beta in Vivo
  • Eric Rondeau, Hopital Tenon, France
  • Non-muscle alpha-actinin-4 interacts with Plasminogen Activator Inhibitor Type-1 (PAI-1)
  • PD Dr Viktor Magdolen, Clinical Research Unit, Frauenklinik der TU Muenchen, Germany
  • PAI-1 as an Example for a Novel Approach in Rational Drug Design
  • Bart M De Taeye, KULeuven, Belgium